Dabur India expects 10%+ consolidated growth in Q1 FY24

However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.

GE HealthCare partners with Elekta to expand access to precision radiation therapy solutions in India

Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy

Merck India appoints Pratima Reddy as Country Speaker

Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India

Granules India successfully completes Two US FDA Audits in a span of 2 weeks

The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.

Shilpa Medicare launches Lenvatinib Capsules in India under the brand name Lenshil

The company is already marketing the 4 mg and 10 mg strengths

Granules India and Central Bureau of Narcotics unite to tackle drug abuse

Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society

Aurobindo's subsidiary to withdraw application for EU marketing authorization of two biosimilars

This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA

Industry needs to establish a self-regulatory body to maintain the quality of the pharma products, says Dr Mandaviya

Dr. Reddy's enters the trade generics business in India

Dr. Reddy's aims to roll out its trade generics across cities and towns in India

Natural Capsules announces strategic investment by Somerset Indus Capital Partners